Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2230 of 6351
-
Can a bench press between squats supercharge your jump?
Knowledge-focused CompletedThe goal of this clinical trial is to learn whether adding a moderate-load bench press exercise during the recovery periods between sets of back squats affects subsequent jumping performance in competitive male basketball players. The main questions it aims to answer are: Does a…
Sponsor: The Jerzy Kukuczka Academy of Physical Education in Katowice • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Can eye movements in VR reveal mental health conditions?
Diagnosis OngoingSchizophrenia (SCZ), bipolar disorder (BP), and depression (DEP) are systematically associated with a severe impairment of the overall abilities of patients, which precludes them from functioning adequately in daily life. A large body of literature emphasises the importance of id…
Sponsor: Etablissement Public de Santé Barthélemy Durand • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
Can a blood test tell who will respond to lung cancer immunotherapy?
Knowledge-focused Recruiting nowImmunotherapy has helped improve the prognosis of metastatic lung cancer. However, only about 40% of patients respond to conventional immunotherapy with anti-PD(L)-1 agents. This research aims to identify biomarkers of response to immunotherapy at the tumor level and to character…
Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Hemp compounds tested as natural relief for menopause
Symptom relief Recruiting nowThe purpose of the study is to examine the impact of hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.
Phase 2 • Sponsor: Washington State University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Fighting HIV stigma: a cultural approach to keep patients in care
Disease control Recruiting nowThis study is being done because the investigators want to learn about how stigma and culture in Indonesia affects how much contact people living with HIV have with the healthcare system and also how it might affect their health status.
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Digital twins could make aorta surgery safer and smarter
Knowledge-focused Recruiting nowThe study aims to collect clinical data and pseudonymized CT images of patients undergoing TEVAR in order to create an anatomical digital twin capable of simulating procedural outcomes and training machine learning (ML) algorithms. This approach will support predictive models tha…
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Can a dashboard turn patient data into better arthritis care?
Knowledge-focused CompletedChronic health conditions are often managed in secondary care services that are facing long waiting lists, limited appointment times, and financial pressures. With the increasing availability of mobile devices including smartphones and wearables, patients can collect vast amounts…
Sponsor: Royal United Hospitals Bath NHS Foundation Trust • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
New study tests whether eating by Cancer-Fighting guidelines can lower risk
Prevention Recruiting nowCancer is a leading cause of death and will affect many people in their lifetimes. Organizations such as the American Cancer Society and the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) have noted that dietary quality is a key factor influencing c…
Sponsor: Drexel University • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
Stool test strategy aims to prevent UC Flare-Ups
Disease control Not yet recruitingDesign: Multicenter, Open-Label, Randomized, Parallel Controlled Allocation: 1:1 Randomization Masking: Open-label (outcome assessors blinded for endoscopy) Primary Purpose: Treatment Strategy Evaluation Phase: Phase IV (Post-Marketing Surveillance)
Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a simple Post-Surgery plan boost recovery for stomach cancer patients?
Symptom relief By invitation onlyThis study was conducted by Qilu Hospital and five other renowned medical centers, aiming to evaluate the impact of early structured postoperative intervention on quality of life and prognosis in patients with gastric cancer after neoadjuvant therapy.
Sponsor: Qilu Hospital of Shandong University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New shockwave therapy could clear blocked heart arteries without major surgery
Disease control Not yet recruitingThis study aims to investigate the efficacy and safety of intravascular lithotripsy (IVL) balloon in treating coronary calcified lesions at our center.
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a Steroid-Sparing cocktail tame chemo nausea?
Symptom relief Recruiting nowA phase II study evaluating dexamethasone sparing regimen with olanzapine and palonosetron for patients receiving high dose cisplatin to prevent chemotherapy induced nausea and vomiting
Phase 2 • Sponsor: Mahidol University • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Smart patch keeps watch after surgery — could it save lives by catching trouble early?
Knowledge-focused Recruiting nowThis study aims to evaluate whether continuous vital sign monitoring with wearable devices can help detect postoperative complications in surgical ward earlier than standard hospital monitoring. In particular, the goal of this observational study is to evaluate if the wireless we…
Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
New device zaps remaining cancer cells during breast surgery
Disease control Recruiting nowThis study aims to assess the safety and clinical accuracy of the SIRA-1000, SIRA® RFA Electrosurgical Device in ablating margins post-lumpectomy in patients undergoing breast conserving surgery for breast cancer. Radiofrequency ablation, or RFA, uses radio waves to create heat, …
Sponsor: Innoblative Designs, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New dashboard aims to boost PrEP access and cut HIV disparities
Prevention Recruiting nowThe purpose of this study is to enhance and evaluate the implementation of a PrEP Care Continuum data dashboard across seven distinct clinical sites in Alabama. By leveraging real-time data and fostering collaborative partnerships, this project aims to accurately visualize care d…
Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Jun 27, 2026 09:07 UTC
-
Blood test may predict spinal injury recovery
Knowledge-focused Recruiting nowTo determine the accuracy of serum NF-L and GFAP levels (ie the biomarkers) at different time points postinjury for predicting the severity of neurologic impairment at 6 months postinjury as either motor complete (AIS grade A/B) or motor incomplete (AIS grade C/D) a group of pati…
Sponsor: AO Foundation, AO Spine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New diabetes drug CX11 shows promise in major trial
Disease control Recruiting nowThis study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good blood sugar control while taking a steady dose of metformin, with or without a steady dose of an SGLT2 inhibitor, for at least 90 days. Th…
Phase 2 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New eczema drug shows promise in Mid-Stage trial
Symptom relief Recruiting nowThe primary objective of this Phase 2 study is to evaluate the efficacy and safety of IBI3002 in patients with moderate to severe Atopic Dermatitis (AD).
Phase 2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New shot could control blood pressure for months
Disease control Not yet recruitingThe purpose of this study is to evaluate the efficacy, safety and tolerability of IBI3016 or placebo, given subcutaneously, every 3 or 6 months, at different dose levels in patients with mild to moderate hypertension
Phase 2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Experimental drug aims to curb meth high in small trial
Disease control Recruiting nowThe purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of four single, increasing doses of CS-1103, given by intravenous (IV) infusion in otherwise healthy, non-treatment seeking participants with methamphetamine use disorder in the presence of a clini…
Phase 2 • Sponsor: Clear Scientific, Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC